Related Experiment Video

Updated: Jun 4, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

Comparing the 2010 North American and European atrial fibrillation guidelines

Anne M Gillis1, Allan C Skanes

  • 1Department of Cardiac Sciences, University of Calgary and Libin Cardiovascular Institute of Alberta, Calgary, Alberta, Canada. amgillis@ucalgary.ca

The Canadian Journal of Cardiology
|February 19, 2011
PubMed

Insights

This review compares 2010 atrial fibrillation (AF) guidelines from ACCF/AHA/HRS, CCS, and ESC. Key differences include rate control targets, antiarrhythmic drug use, and stroke prevention strategies like dabigatran.

Area of Science:

  • Cardiology
  • Clinical Guidelines
  • Atrial Fibrillation Management

Background:

  • Established guidelines for atrial fibrillation (AF) management exist from major cardiovascular societies.
  • These guidelines evolve to incorporate new evidence and therapeutic options.
  • Comparing guideline differences is crucial for clinical practice harmonization.

Purpose of the Study:

  • To compare key differences in the 2010 guidelines on atrial fibrillation (AF) from the American College of Cardiology Foundation/American Heart Association/Heart Rhythm Society (ACCF/AHA/HRS), Canadian Cardiovascular Society (CCS), and European Society of Cardiology (ESC).
  • To highlight variations in recommendations for rate control, antiarrhythmic drug therapy, catheter ablation, and stroke prevention.

Main Methods:

  • Comparative analysis of the 2010 ACCF/AHA/HRS, CCS, and ESC guidelines for atrial fibrillation (AF).
  • Focus on specific recommendations regarding ventricular rate control, antiarrhythmic drug selection, use of dronedarone, catheter ablation indications, and anticoagulation for stroke prevention.

Main Results:

  • All guidelines suggest more lenient ventricular rate control targets, with CCS recommending <100 bpm at rest and ACCF/AHA/HRS and ESC allowing <110 bpm with conditions.
  • CCS guidelines differ in restricting Class IC drugs or sotalol with left ventricular hypertrophy and do not specifically recommend dronedarone for reducing AF-related hospitalizations.
  • ACCF/AHA/HRS strongly recommends catheter ablation for paroxysmal AF after one antiarrhythmic drug failure, unlike the conditional recommendations from CCS and ESC.
  • CCS guidelines uniquely recommend dabigatran for stroke prevention in high-risk patients, preferring it over warfarin for most groups.

Conclusions:

  • Significant variations exist among major 2010 AF guidelines, particularly concerning rate control, drug therapy, ablation, and novel anticoagulants.
  • The CCS guidelines present distinct recommendations, notably favoring dabigatran for stroke prevention.
  • Understanding these guideline discrepancies is essential for clinicians managing patients with atrial fibrillation.

More Related Videos

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

Robotic Ablation of Atrial Fibrillation11:21

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

Related Concept Videos

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...